Cargando…

Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline

Detalles Bibliográficos
Autores principales: Volontè, Martina, Isoletta, Eugenio, Gordon, Shaul, Foiadelli, Thomas, Bassanese, Francesco, Rossi, Alessandra, Marseglia, Gian Luigi, Savasta, Salvatore, Brazzelli, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541585/
https://www.ncbi.nlm.nih.gov/pubmed/35638252
http://dx.doi.org/10.1111/dth.15607
_version_ 1784803958576906240
author Volontè, Martina
Isoletta, Eugenio
Gordon, Shaul
Foiadelli, Thomas
Bassanese, Francesco
Rossi, Alessandra
Marseglia, Gian Luigi
Savasta, Salvatore
Brazzelli, Valeria
author_facet Volontè, Martina
Isoletta, Eugenio
Gordon, Shaul
Foiadelli, Thomas
Bassanese, Francesco
Rossi, Alessandra
Marseglia, Gian Luigi
Savasta, Salvatore
Brazzelli, Valeria
author_sort Volontè, Martina
collection PubMed
description
format Online
Article
Text
id pubmed-9541585
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-95415852022-10-14 Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline Volontè, Martina Isoletta, Eugenio Gordon, Shaul Foiadelli, Thomas Bassanese, Francesco Rossi, Alessandra Marseglia, Gian Luigi Savasta, Salvatore Brazzelli, Valeria Dermatol Ther Letters John Wiley & Sons, Inc. 2022-06-09 2022-08 /pmc/articles/PMC9541585/ /pubmed/35638252 http://dx.doi.org/10.1111/dth.15607 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Volontè, Martina
Isoletta, Eugenio
Gordon, Shaul
Foiadelli, Thomas
Bassanese, Francesco
Rossi, Alessandra
Marseglia, Gian Luigi
Savasta, Salvatore
Brazzelli, Valeria
Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title_full Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title_fullStr Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title_full_unstemmed Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title_short Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline
title_sort acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: good results with doxycycline
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541585/
https://www.ncbi.nlm.nih.gov/pubmed/35638252
http://dx.doi.org/10.1111/dth.15607
work_keys_str_mv AT volontemartina acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT isolettaeugenio acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT gordonshaul acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT foiadellithomas acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT bassanesefrancesco acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT rossialessandra acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT marsegliagianluigi acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT savastasalvatore acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline
AT brazzellivaleria acneiformrashasasideeffectofselumetinibinachildwithneurofibromatosistype1treatedforinoperableplexiformneurofibromasgoodresultswithdoxycycline